Tuning a 96-well microtiter plate fluorescence-based assay to identify AGE inhibitors in crude plant extracts

Molecules

Volumn 18, Issue 11, 2013, Pages 14320-14339

  Séro, Luc ^a,b   Sanguinet, Lionel ^b   Blanchard, Patricia ^a   Dang, Bach Tai ^a   Morel, Sylvie ^a   Richomme, Pascal ^a   Séraphin, Denis ^a   Derbré, Séverine ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

Advanced glycation end products; Automation; Fluorescence; Natural products; Pentosidine; Plant extract screening; Vesperlysines

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE; DRUG DERIVATIVE; LYSINE; PENTOSIDINE; PLANT EXTRACT;

ARTICLE; CHEMISTRY; FLUORESCENCE;

ARGININE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; LYSINE; PLANT EXTRACTS;

EID: 84888587511     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules181114320     Document Type: Article

References (68)

1. Maillard, L.C. Action des acides aminés sur les sucres; formation des mélanoïdes par voie méthodique. C. R. Acad. Sci. 1912, 154, 66-67.
2. Wolffenbuttel, B.H.; Giordano, D.; Founds, H.W.; Bucala, R. Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 1996, 347, 513-515.
3. Reddy, V.P.; Beyaz, A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov. Today 2006, 11, 646-654.
4. Peyroux, J.; Sternberg, M. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. Pathol. Biol. 2006, 54, 405-419.
5. WHO, Diabetes. Available online: http://www.who.int/topics/diabetes- mellitus/en/ (accessed 20 June 2012).
6. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820.
7. Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation end-products: A review. Diabetologia 2001, 44, 129-146.
8. Forbes, J.M.; Yee, L.T.L.; Thallas, V.; Lassila, M.; Candido, R.; Jandeleit-Dahm, K.A.; Thomas, M.C.; Burns, W.C.; Deemer, E.K.; Thorpe, S.M.; Cooper, M.E.; et al. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 2004, 53, 1813-1823.
9. Yamamoto, Y.; Doi, T.; Kato, I.; Shinohara, H.; Sakurai, S.; Yonekura, H.; Watanabe, T.; Myint, K.M.; Harashima, A.I.; Takeuchi, M.; et al. Receptor for advanced glycation end products is a promising target of diabetic nephropathy. Ann. N.Y. Acad. Sci. 2005, 1043, 562-566.
10. Stitt, A.W. The maillard reaction in eye diseases. Ann. N.Y. Acad. Sci. 2005, 1043, 582-97.
11. DiabetesCare. Standards of medical care in diabetes-2012. Diabetes Care 2012, 35 (Suppl. 1), S11-S63.
12. Chen, Y.F.; Roan, H.Y.; Lii, C.K.; Huang, Y.C.; Wang, T.S. Relationship between antioxidant and antiglycation ability of saponins, polyphenols, and polysaccharides in Chinese herbal medicines used to treat diabetes. J. Med. Plants Res. 2011, 5, 2322-2331.
13. Harris, C.S.; Beaulieu, L.-P.; Fraser, M.-H.; McIntyre, K.L.; Owen, P.L.; Martineau, L.C.; Cuerrier, A.; Johns, T.; Haddad, P.S.; Bennett, S.A.L.; et al. Inhibition of advanced glycation end product formation by medicinal plant extracts correlates with phenolic metabolites and antioxidant activity. Planta Med. 2011, 77, 196-204.
14. Peng, X.; Ma, J.; Chen, F.; Wang, M. Naturally occurring inhibitors against the formation of advanced glycation end-products. Food Funct. 2011, 2, 289-301.
15. Takeuchi, M.; Yamagishi, S.-I. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease. Curr. Pharm. Des. 2008, 14, 973-978.
16. DeGroot, J. The AGE of the matrix: Chemistry, consequence and cure. Curr. Opin. Pharmacol. 2004, 4, 301-305.
17. Grillo, M.A.; Colombatto, S. Advanced glycation end-products (AGEs): Involvement in aging and in neurodegenerative diseases. Amino Acids 2008, 35, 29-36.
18. Khalifah, R.G.; Baynes, J.W.; Hudson, B.G. Amadorins: Novel post-Amadori inhibitors of advanced glycation reactions. Biochem. Biophys. Res. Commun. 1999, 257, 251-258.
19. Monnier, V.M. Intervention against the Maillard reaction in vivo. Arch. Biochem. Biophys. 2003, 419, 1-15.
20. Wang, J.; van der Heijden, R.; Spruit, S.; Hankermeier, T.; Chan, K.; van der Greef, J.; Xu, G.; Wang, M. Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J. Ethnopharmacol. 2009, 126, 31-41.
21. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 Years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311-335.
22. Bailey, C.J.; Day, C. Metformin: Its botanical background. Pract. Diabetes Int. 2004, 21, 115-117.
23. Saraiva, M.A.; Borges, C.M.; Florêncio, M.H. Towards the control and inhibition of glycation- the role of the guanidine reaction center with aldehydic and diketonic dicarbonyls. A mass spectrometry study. J. Mass Spectrom. 2006, 41, 1346-1368.
24. Vinson, J.A.; Howard, T.B. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 1996, 7, 659-663.
25. Wu, C.-H.; Huang, S.-M.; Lin, J.-A.; Yen, G.-C. Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct. 2011, 2, 224-234.
26. Matsuura, N.; Aradate, T.; Sasaki, C.; Kojima, H.; Ohara, M.; Hasegawa, J.; Ubukata, M. Screening system for the Maillard reaction inhibitor from natural product extracts. J. Health Sci. 2002, 48, 520-526.
27. Rahbar, S.; Yerneni, K.K.; Scott, S.; Gonzales, N.; Lalezari, I. Novel inhibitors of advanced glycation endproducts (Part II). Mol. Cell Biol. Res. Commun. 2000, 3, 360-366.
28. Nagai, R.; Fujiwara, Y.; Mera, K.; Yamagata, K.; Sakashita, N.; Takeya, M. Immunochemical detection of N?-(carboxyethyl)lysine using a specific antibody. J. Immunol. Methods 2008, 332, 112-120.
29. Motomura, K.; Fujiwara, Y.; Kiyota, N.; Tsurushima, K.; Takeya, M.; Nohara, T.; Nagai, R.; Ikeda, T. Astragalosides isolated from the root of Astragalus Radix inhibit the formation of advanced glycation end products. J. Agric. Food Chem. 2009, 57, 7666-7672.
30. Fatima, S.; Jairajpuri, D.S.; Saleemuddin, M. A procedure for the rapid screening of Maillard reaction inhibitors. J. Biochem. Biophys. Meth. 2008, 70, 958-965.
31. Nakamura, K.; Nakazawa, Y.; Ienaga, K. Acid-stable fluorescent advanced glycation end products: Vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem. Biophys. Res. Commun. 1997, 232, 227-230.
32. Sell, D.R.; Monnier, V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J. Biol. Chem. 1989, 264, 21597-21602.
33. Watanabe, H.; Iwaki, S.; Aida, K.; Hayase, F. Formation and determination of a-dicarbonyls and an AGE cross-link, pyrropyridine in glycated proteins and in vivo. Int. Congr. Ser. 2002, 1245, 153-156.
34. Vashishth, D. Advanced glycation end-products and bone fractures. BoneKEy Osteovision 2009, 6, 268-278.
35. Pongor, S.; Ulrich, P.C.; Bencsath, F.A.; Cerami, A. Aging of proteins: Isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc. Natl. Acad. Sci. USA 1984, 81, 2684-2688.
36. Shipanova, I.N.; Glomb, M.A.; Nagaraj, R.H. Protein modification by methylglyoxal: Chemical nature and synthetic mechanism of a major fluorescent adduct. Arch. Biochem. Biophys. 1997, 344, 29-36.
37. Derbré, S.; Gatto, J.; Pelleray, A.; Coulon, L.; Séraphin, D.; Richomme, P. Automating a 96-well microtiter plate assay for identification of AGEs inhibitors or inducers: Application to the screening of a small natural compounds library. Anal. Bioanal. Chem. 2010, 398, 1747-1758.
38. Beisswenger, P.J.; Howell, S.; Mackenzie, T.; Corstjens, H.; Muizzuddin, N.; Matsui, M.S. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in Human skin without diabetes. Diabetes Technol. Ther. 2012, 14, 285-292.
39. The nomenclature used in the manuscript does not refer to the structure of AGEs but rather to their fluorescent properties.
40. 370 nm and 440 nm were most commonly used as excitation and emission wavelengths.
41. Chompoo, J.; Upadhyay, A.; Kishimoto, W.; Makise, T.; Tawata, S. Advanced glycation end products inhibitors from Alpinia zerumbet rhizomes. Food Chemistry 2011, 129, 709-715.
42. Palanisamy, U.D.; Ling, L.T.; Manaharan, T.; Appleton, D. Rapid isolation of geraniin from Nephelium lappaceum rind waste and its anti-hyperglycemic activity. Food Chem. 2011, 127, 21-27.
43. Wirasathien, L.; Pengsuparp, T.; Suttisri, R.; Ueda, H.; Moriyasu, M.; Kawanishi, K. Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr. Phytomedicine 2007, 14, 546-550.
44. Jung, H.A.; Jin, S.E.; Park, J.-S.; Choi, J.S. Antidiabetic complications and anti-alzheimer activities of sophoflavescenol, a prenylated flavonol from Sophora flavescens, and its structure activity relationship. Phytother. Res. 2011, 25, 709-715.
45. Ardestani, A.; Yazdanparast, R. Inhibitory effects of ethyl acetate extract of Teucrium polium on in vitro protein glycoxidation. Food Chem. Toxicol. 2007, 45, 2402-2411.
46. Zhang, J.-H.; Chung, T.D. Y.; Oldenburg, K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4, 67-73.
47. Zhang, X.D. Novel analytic criteria and effective plate designs for quality control in genome-scale RNAi screens. J. Biomol. Screen. 2008, 13, 363-377.
48. Zhang, X.D. A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays. Genomics 2007, 89, 552-561.
49. Monnier, V.M.; Bautista, O.; Kenny, D.; Sell, D.R.; Fogarty, J.; Dahms, W.; Cleary, P.A.; Lachin, J.; Genuth, S. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes-Relevance of glycated collagen products versus HbA(1c) as markers of diabetic complications. Diabetes 1999, 48, 870-880.
50. Mezzetti, A.; Protti, S.; Lapouge, C.; Cornard, J.-P. Protic equilibria as the key factor of quercetin emission in solution. Relevance to biochemical and analytical studies. Phys. Chem. Chem. Phys. 2011, 13, 6858-6864.
51. Bark, K.-M.; Yeom, J.-E.; Yang, J.-I.; Yang, I.-J.; Park, C.-H.; Park, H.-R. Spectroscopic studies on the oxidation of catechin in aqueous solution. Bull. Korean Chem. Soc. 2011, 32, 3443-3447.
52. Bellow, S.; Latouche, G.; Brown, S.C.; Poutaraud, A.; Cerovic, Z.G. In vivo localization at the cellular level of stilbene fluorescence induced by Plasmopara viticola in grapevine leaves. J. Exp. Bot. 2012, 63, 3697-3707.
53. Diaz, M.S.; Freile, M.L.; Gutierrez, M.I. Solvent effect on the UV/Vis absorption and fluorescence spectroscopic properties of berberine. Photochem. Photobiol. Sci. 2009, 8, 970-974.
54. Gurkan, T. Fluorimetric analysis of alkaloids. Determination of serpentine, yohimbine, and boldine. Mikrochim. Acta 1976, 65, 173-180.
55. Morales, F.; Cartelat, A.; Alvarez-Fernandez, A.; Moya, I.; Cerovic, Z.G. Time-resolved spectral studies of blue-green fluorescence of artichoke (Cynara cardunculus L. var. ccolymus) leaves: Identification of chlorogenic acid as one of the major fluorophores and age-mediated changes. J. Agric. Food Chem. 2005, 53, 9668-9678.
56. Smith, G.J.; Haskell, T.G. The fluorescent oxidation products of dihydroxyphenylalanine and its esters. J. Photochem. Photobiol. B 2000, 55, 103-108.
57. Asano, T.; Sadakane, C.; Ishihara, K.; Yanagisawa, T.; Kimura, M.; Kamei, H. High-performance liquid chromatographic assay with fluorescence detection for the determination of cephaeline and emetine in human plasma and urine. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 757, 197-206.
58. Fink, D.W.; Koehler, W.R. pH effects on fluorescence of umbelliferone. Anal. Chem. 1970, 42, 990-993.
59. Haugland, R.P. Handbook of Fluorescent Probes and Research Products, 9th ed.; Molecular Probes: Eugene, OR, USA, 2002; p. 963.
60. Nagai, R.; Murray, D.B.; Metz, T.O.; Baynes, J.W. Chelation: A fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 2012, 61, 549-559.
61. Sigmaplot Software, version 12.5; Systat Software GmbH: Erkrath, Germany, 2011.
62. Palmer, M.H.; Walker, I.C.; Guest, M.F.; Siggel, M.R. F. The electronic states of the azines. VII. 1,2,4-triazine, studied by photon absorption, near-threshold electron energy loss spectroscopy and ab initio multi-reference configuration interaction calculations. Chem. Phys. 1995, 201, 381-391.
63. Meyers, A.I.; Elworthy, T.R. Chiral formamidines-The total asymmetric-synthesis of (-)-8- azaestrone and related (-)-8-aza-12-oxo-17- desoxoestrone. J. Org. Chem. 1992, 57, 4732-4740.
64. Bruneton, J. Pharmacognosy, Phytochemistry, Medicinal Plants, 2nd ed.; Editions Tec & Doc: Paris, France, 2008; p. 1088.
65. Ferchichi, L.; Derbré, S.; Mahmood, K.; Touré, K.; Guilet, D.; Litaudon, M.; Awang, K.; Hadi, A.H.A.; Le Ray, A.M.; Richomme, P. Bioguided fractionation and isolation of natural inhibitors of advanced glycation end-products (AGEs) from Calophyllum flavoramulum. Phytochemistry 2012, 78, 98-106.
66. Rusak, G.; Komes, D.; Likic, S.; Horzic, D.; Kovac, M. Phenolic content and antioxidative capacity of green and white tea extracts depending on extraction conditions and the solvent used. Food Chem. 2008, 110, 852-858.
67. Wichtl, M.; Anton, R. Plantes Thérapeutiques, 2nd ed.; Editions Tec & Doc: Paris, France, 2003; p. 689.
68. Morel, S.; Landreau, A.; Nguyen, V.H.; Derbré, S.; Grellier, P.; Le Pape, P.; Pagniez, F.; Litaudon, M.; Richomme, P. Preparative isolation, fast centrifugal partition chromatography purification and biological activity of cajaflavanone from Derris ferruginea Stems. Phytochem. Anal. 2012, 23, 152-158.